Nuchal translucency and ductus venosus blood flow as early sonographic markers of thanatophoric dysplasia: A case report

Fetal Diagnosis and Therapy

Volumn 19, Issue 3, 2004, Pages 241-245

  Ferreira, Anabela ^a   Matias, Alexandra ^a   Brandão, Otília ^a   Montenegro, Nuno ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Ductus venosus flowmetry; Nuchal translucency; Thanatophoric dysplasia

Indexed keywords

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE MARKER; DUCTUS VENOSUS; FETUS; FETUS ECHOGRAPHY; HUMAN; LABORATORY TEST; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THANATOPHORIC DWARFISM; VEIN BLOOD FLOW;

ABORTION, INDUCED; ADULT; FEMALE; HUMANS; LIVER; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REGIONAL BLOOD FLOW; SPINE; THANATOPHORIC DYSPLASIA; ULTRASONOGRAPHY, PRENATAL; VEINS;

EID: 1842635535     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076705     Document Type: Article

References (27)

1. International Working Group on Constitutional Diseases of Bone: International nomenclature and classification of the osteochondrodysplasias (1997). Am J Med Genet 1998;79:376-382.
2. Romero R, Athanassiadis AP, Jeanty P: Fetal skeletal anomalies. Radiol Clin North Am 1990;28:75-99.
3. Schrander-Stumpel C, De Die-Smulders C, Offermans J, Vandervijver N, Herbergs J, Blakburn W: Short-limb dwarfism: A prenatal challenge. 4th Int Skeletal Dysplasia Meet, Baden-Baden, 1999.
4. Maroteaux P, Lamy M, Rober J-M: Le nanisme thanatophore. Presse Méd 1967;49:2519-2524.
5. Orlioli IM, Castilla EE, Barbosa-Neto JG: The birth prevalence rates for skeletal dysplasias. J Med Genet 1986;23:328-332.
6. Tonoki H: A boy with thanatophoric dysplasia surviving 212 days. Clin Genet 1987;30:415-416.
7. Stensvold E, Ek J, Hovland AR: An infant with thanatophoric dysplasia surviving 169 days. Clin Genet 1986;29:157-159.
8. Sawai H, Komori S, Ida A, Henmi T, Bessho T, Koyama K: Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results. Pranatal Diagn 1999;19:21-24.
9. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ: Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995;9:321-328.
10. Jasnosz KM, MacPherson TA: Perinatal Pathology casebook. Thanatophoric dysplasia with cloverleaf skull. J Perinatol 1993;13:162-164.
11. Kölble N, Sobetzko D, Ersch J, Stallmach T, Eich G, Huch R, Huch A, Superti-Furga A, Wisser J: Diagnosis of skeletal dysplasia by multidisciplinary assessment: A report of two cases of thanatophoric dysplasia. Ultrasound Obstet Gynecol 2002;19:92-98.
12. Rousseau F, Boneventure J, Legeai Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A: Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994;371:252-254.
13. Chen C-P, Chern S-R, Shih J-C, Wang W, Yeh L-F, Chang J-Y, Tzen S-Y: Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenatal Diagn 2001;21:89-95.
14. Reardon W: Skeletal dysplasias detectable by DNA analysis. Prenatal Diagn 1996:16:1221-1236.
15. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, Boneventure J, Narcy F, Sanak M: Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet 1995;10:11-12.
16. Reardon W: Skeletal dysplasias detectable by DNA analysis. Prenatal Diagn 1996;16:1221-1236.
17. Tretter AE, Saunders RC, Meyers CM, Dungan JS, Grumbach K, Sun CC, Campbell AB, Wulfsberg EA: Antenatal diagnosis of lethal skeletal dysplasias. Am J Med Genet 1998;75:518-522.
18. Stoll C, Doray B, Favre R, Viville B, Langer B, Dreyfus M: A report of the diagnostic and prognostic accuracy of prenatal sonographic diagnosis of skeletal dysplasias. 4th Int Skeletal Dysplasia Meet, Baden-Baden, 1999.
19. Gabrielli S, FalcoP, Pilu G, Perolo A, Milano B, Bovicelli: Can transvaginal fetal biometry be considered a useful tool for early detection of skeletal dysplasias in high-risk patients? Ultrasound Obstet Gynecol 1999;13:107-111.
20. Sharony R, Browne C, Lachman RS, Rimoin DL: Prenatal diagnosis of the skeletal dysplasias. Am J Obstet Gynecol 1993;169:668-675.
21. Gaffney G, Manning N, Boyd PA, Rai V, Gould S, Chamberlain P: Prenatal sonographic diagnosis of skeletal dysplasias - A report of the diagnostic and prognostic accuracy in 35 cases. Prenatal Diagn 1998;18:357-362.
22. Kassanos D, Botsis D, Katassos T, Panayotopoylos N, Zourlas P: Prenatal sonographic diagnosis of thanatophoric dwarfism. Int J Gynecol Obstet 1991;34:373-376.
23. Hall C: Pre-natal diagnosis of lethal dwarfism using ultrasound. Radiogr Today 1991;57:22-23.
24. Gonçalves L, Jeanty P: Fetal biometry of skeletal dysplasia. A multicentric study. J Ultrasound Med 1994;13:977-985.
25. von Kaisenberg CS, Fritzer E, Kuhlig H, Jonat W: Transabdominal fetal biometry at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2002;20:564-574.
26. Benacerraf BR, Lister JE, DuPonte BL: First-trimester diagnosis of fetal abnormalities. A report of three cases. J Reprod Med 1988;33:777-780.
27. Rahemtullah A, Mc Gillivray B, Wilson RD: Suspected skeletal dysplasias: Femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome. Am J Obstet Gynecol 1997;177:864-869.